Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. International Cardiovascular Research Journal
  4. Articles

  5. Association Assessment of Paraoxonase 1 Gene Polymorphism with Coronary Artery Disease in Golestan, Iran
  6. Scopus by Title (Ref)

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

homeHome
play_circleCurrent IssuelistAll Issuesplay_circleIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
errorJournal InformationschoolBoards & CommitteesshareIndexing and Listing Sourcesbar_chartJournal MetricsbalancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormheadphonesSupportphone_in_talkContact Us
questionAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. MirSNPs in clopidogrel metabolism genes predict cardiovascular disease risk: A case-control study and meta-analysis

- Sharma A.R. , et al.

2. Association of tumor necrosis factor-alpha gene promoter polymorphism and its mRNA expression level in coronary artery disease

- Nejati P. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards & Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.